P2-020: Serum Granulocyte Colony Stimulating Factor and Alzheimer's Disease

2011 ◽  
Vol 7 ◽  
pp. S313-S313
Author(s):  
Robert Barber ◽  
Sid O'Bryant ◽  
Joan Reisch ◽  
Rachelle Doody ◽  
Thomas Fairchild ◽  
...  
2012 ◽  
Vol 31 (4) ◽  
pp. 843-855 ◽  
Author(s):  
Juan Sanchez-Ramos ◽  
Cynthia Cimino ◽  
Ross Avila ◽  
Amanda Rowe ◽  
Ren Chen ◽  
...  

2005 ◽  
Vol 33 (6) ◽  
pp. 654-660 ◽  
Author(s):  
T Kawata ◽  
K Tsutsui ◽  
S Kohno ◽  
M Kaku ◽  
T Fujita ◽  
...  

The deposition of amyloid β (Aβ) protein is a neuropathological change that characterizes Alzheimer's disease. Animals with the osteopetrosis (op/op) mutation suffer from a general skeletal sclerosis, a significantly reduced number of macrophages and osteoclasts in various tissues, and have no systemic macrophage colony stimulating factor (M-CSF). This study examined the effect that M-CSF injections had on Aβ deposition and microglial cell distribution in the brains of normal and op/op mice. Aβ-positive plaques were detected in the cerebral cortex of op/op mice, but not in normal mice. M-CSF reduced the numbers of Aβ-positive plaques in op/op mice. The microglial cell population was reduced in op/op mice compared with normal mice, and M-CSF increased the numbers to 65.8% of that observed in normal mice. Our results suggest that a clearer understanding of the role that microglial cells play in Aβ deposition may help determine the mechanisms involved in the pathogenesis of Alzheimer's disease.


Sign in / Sign up

Export Citation Format

Share Document